David Belada

基本信息

浏览量：158

职业迁徙

个人简介

Skills and Expertise
Hematologic Neoplasms
Lymphoma

研究兴趣

论文共 308 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Several Factors That Predict the Outcome of Large B-cell Lymphoma Patients Who Relapse/progress after Chimeric Antigen Receptor (CAR) T-cell Therapy Can Be Identified Before Cell Administration

Alice Sykorova,Frantisek Folber,Kamila Polgarova,Heidi Mocikova,Juraj Duras,Katerina Steinerova,Ales Obr,Adriana Heindorfer,Miriam Ladicka, Lubica Lukacova, Erika Cellarova,Ivana Plamenova,David Belada,Andrea Janikova,Marek Trneny, Tereza Jancarkova,Vit Prochazka,Andrej Vranovsky, Margareta Kralikova,Jan Vydra,Lukas Smolej,Lubos Drgona, Martin Sedmina,Eva Cermakova,Robert Pytlik

CANCER MEDICINEno. 17 (2024)

引用0浏览0WOS引用

Abstract 3732: Peripheral Pharmacodynamic Activity of Epcoritamab As Monotherapy and in Combination with Rituximab + Lenalidomide in Patients with Follicular Lymphoma

Han Si,Jimin Zhang,Monica Wielgos-Bonvallet,Lorenzo Falchi,Kim Linton,Wojciech Jurczak,David Belada,Isil Altintas,Mariana Sacchi,Elena Favaro,Ali Rana,Daniela Hoehn,David Soong,Christopher W. Chiu,Maria Jure-Kunkel

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Efficacy and Safety of Ibrutinib Plus Venetoclax in Patients with Mantle Cell Lymphoma (MCL) and TP53 Mutations in the SYMPATICO Study

Michael Wang,Wojciech Jurczak,Marek Trneny,David Belada,Tomasz Wrobel,Nilanjan Ghosh,Mary-Margaret Keating, Tom van Meerten,Ruben Fernandez-Alvarez,Gottfried von Keudell, Catherine Thieblemont, Frederic Peyrade,Marc Andre,Marc Hoffmann,Maoko Naganuma,Edith Szafer-Glusman,Jennifer Lin,James P. Dean,Jutta Katrin Neuenburg,Constantine S. Tam

Journal of Clinical Oncologyno. 16_suppl (2024): 7007-7007

引用0浏览0引用

HTA73 Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL)

J. Novak, P. Vodicka,A. Janikova,D. Belada,S. Motylova,M. Pour,J. Dolezel, K. Krihova, J. Muzik,D. Skalicky,M. Trneny

Value in Healthno. 6 (2024): S257-S257

引用0浏览0引用

Effectiveness of Tixagevimab/cilgavimab in Patients with Hematological Malignancies As a Pre-Exposure Prophylaxis to Prevent Severe COVID-19: a Czech Retrospective Multicenter Study

Ivo Demel,David Skopal, Eliška Šafránková,Petra Rozsívalová,Pavel Jindra,Jiří Šrámek, Adéla Turková,Jan Vydra, Klára Labská, Jana Vedrová,Martin Čerňan,Tomáš Szotkowski,Heidi Móciková,Lenka Hynková,Ondrej Šušol, Ingrid Kováčová,David Belada,Roman Hájek

ANNALS OF HEMATOLOGYno. 3 (2024): 981-992

引用0浏览0WOS引用

Epcoritamab + GemOx Induces Deep, Durable Responses in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Updated Results from EPCORE NHL-2

Joshua D. Brody,Judit Meszaros Joergensen,David Belada, Regis Costello,Marek Trneny, Umberto Vitolo,David John Lewis,Yasmin Karimi,Anna Sureda,Marc Andre,Bjorn E. Wahlin,Pieternella Lugtenburg, Yajian Jiang,Aqeel Abbas,Yaou Song, Malene Risum,Raul Cordoba

Clinical Lymphoma Myeloma & Leukemia（2024）

引用0浏览0引用

Complex Evaluation of Serum Immunoglobulin Levels in Patients with Chronic Lymphocytic Leukemia: Significant Increase in IgA after First‐line Chemoimmunotherapy

Pavel Vodarek,Dominika Ecsiova,Vladimira Rezacova,Ondrej Soucek,Martin Simkovic,Doris Vokurkova,David Belada,Pavel Zak,Lukas Smolej

Cancer Medicineno. 15 (2024)

引用0浏览0WOS引用

Epcoritamab with Rituximab Plus Lenalidomide (R2) in Previously Untreated (1L) Follicular Lymphoma (FL) and Epcoritamab Maintenance in FL: EPCORE NHL-2 Arms 6 and 7

Leslie A. Lori, Lorenzo Falchi,Joost S. P. Vermaat, Gerardo Musuraca,David Belada,Marcel Nijland,Jacob Haaber Christensen,Fritz Offner,Daniela Hoehn,Jennifer Marek,Liwei Wang, J. P. Mei, Pau Abrisqueta,Joshua D. Brody

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Medical Doctor

论文共 308 篇作者统计合作学者相似作者